These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8307168)

  • 1. Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein.
    Lamb DJ; Leake DS
    FEBS Lett; 1994 Jan; 338(2):122-6. PubMed ID: 8307168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?
    Leake DS
    Atherosclerosis; 1997 Mar; 129(2):149-57. PubMed ID: 9105556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein.
    Lamb DJ; Leake DS
    FEBS Lett; 1994 Sep; 352(1):15-8. PubMed ID: 7925932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidic pH increases the oxidation of LDL by macrophages.
    Morgan J; Leake DS
    FEBS Lett; 1993 Nov; 333(3):275-9. PubMed ID: 8224192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptor.
    Tangirala RK; Mol MJ; Steinberg D
    J Lipid Res; 1996 Apr; 37(4):835-43. PubMed ID: 8732783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of low density lipoprotein by iron or copper at acidic pH.
    Morgan J; Leake DS
    J Lipid Res; 1995 Dec; 36(12):2504-12. PubMed ID: 8847477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human serum, cysteine and histidine inhibit the oxidation of low density lipoprotein less at acidic pH.
    Patterson RA; Leake DS
    FEBS Lett; 1998 Sep; 434(3):317-21. PubMed ID: 9742946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages.
    Lamb DJ; Mitchinson MJ; Leake DS
    FEBS Lett; 1995 Oct; 374(1):12-6. PubMed ID: 7589497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester accumulation in macrophages treated with oxidized low density lipoprotein.
    Ryu BH; Mao FW; Lou P; Gutman RL; Greenspan P
    Biosci Biotechnol Biochem; 1995 Sep; 59(9):1619-22. PubMed ID: 8520107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ
    Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.
    Meyer DF; Mayans MO; Groot PH; Suckling KE; Bruckdorfer KR; Perkins SJ
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):417-26. PubMed ID: 7654177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible role of copper ions in atherogenesis: the Blue Janus.
    Ferns GA; Lamb DJ; Taylor A
    Atherosclerosis; 1997 Sep; 133(2):139-52. PubMed ID: 9298674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxypyridinones and desferrioxamine inhibit macrophage-mediated LDL oxidation by iron but not by copper.
    Lamb DJ; Hider RC; Leake DS
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):234S. PubMed ID: 8224391
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper.
    Carpenter KL; Wilkins GM; Fussell B; Ballantine JA; Taylor SE; Mitchinson MJ; Leake DS
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):625-33. PubMed ID: 7999000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of ascorbate and dehydroascorbate on the oxidation of low-density lipoprotein.
    Stait SE; Leake DS
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):373-81. PubMed ID: 8973543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oxidative modification of low-density lipoproteins by macrophages.
    Leake DS; Rankin SM
    Biochem J; 1990 Sep; 270(3):741-8. PubMed ID: 2122885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway.
    Katsura M; Forster LA; Ferns GA; Anggård EE
    Biochim Biophys Acta; 1994 Jul; 1213(2):231-7. PubMed ID: 8025135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron-ascorbate-phospholipid mediated modification of low density lipoprotein.
    Greenspan P; Yu H; Gutman RL; Mao F; Ryu BH; Lou P
    Biochim Biophys Acta; 1996 Jun; 1301(3):242-8. PubMed ID: 8664335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of pH on the oxidation of low-density lipoprotein by copper and metmyoglobin are different.
    Rodríguez-Malaver AJ; Leake DS; Rice-Evans CA
    FEBS Lett; 1997 Apr; 406(1-2):37-41. PubMed ID: 9109382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL oxidized with iron in the presence of homocysteine/cystine at acidic pH has low cytotoxicity despite high lipid peroxidation.
    Pfanzagl B
    Atherosclerosis; 2006 Aug; 187(2):292-300. PubMed ID: 16256999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.